A study found that daily vitamin D supplements helped slow telomere shortening—the cellular process linked to aging and ...

"Immune Thrombocytopenic Purpura (ITP) Pipeline"DelveInsight's,“Immune Thrombocytopenic Purpura - Pipeline Insight, 2025,” report provides comprehensive insights about 30+ companies and 25+ pipeline ...

Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with ...

The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions. That makes the drug, from the company Evita ...

Kuwaiti authorities have foiled an attempt to smuggle nearly 364kg of Captagon into the country through Shuwaikh Port in Kuwait City, the Interior Ministry has said. Five suspects were arrested after ...

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...

Weight-loss pills could become available on the NHS in future as an alternative to injections, Wes Streeting has said. It comes after the Health Secretary used his conference speech on Tuesday to ...

Hi, it’s Satviki in Mumbai. President Donald Trump’s tariffs reached the health care sector last week. While levies are on patented drugs for now, the outsized reliance on Indian generics, especially ...

QIVIGY is the realization of over 10 years of investments and internal efforts to bring a proprietary IVIG product from concept to commercialization FORT LEE, N.J., Sept. 29, 2025 /PRNewswire/ -- ...

The product is expected to be available in early 2026. The Food and Drug Administration (FDA) has approved Qivigy (immune globulin intravenous [IV], human-kthm) 10% solution for the treatment of ...